Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijayakumar Velu

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Frontiers in Bioscience (Landmark Edition)|March 27, 2024
Chronic Viral Infection Compromises the Quality of Circulating Mucosal-Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory ReceptorsJaisheela Vimali, Yean K Yong, Amudhan Murugesan, et al.
European Journal of Clinical Investigation|December 19, 2015
Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patientsMuttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, et al.
Innate Immunity|June 14, 2017
Decrease of CD69 levels on TCR Vα7.2<sup>+</sup>CD4<sup>+</sup> innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patientsYean K Yong, Hong Y Tan, Alireza Saeidi, et al.
Frontiers in Immunology|December 15, 2025
No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME studyMarisa R Young, C Christina Mehta, Tyree Staple, et al.
Journal of Viral Hepatitis|April 5, 2024
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradicationShanmugam Saravanan, Esaki M Shankar, Ramachandran Vignesh, et al.
Frontiers in Immunology|August 8, 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus MacaquesTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Pathogens and Disease|November 12, 2013
HIV-Mycobacterium tuberculosis co-infection: a 'danger-couple model' of disease pathogenesisEsaki M Shankar, Ramachandran Vignesh, Rada Ellegård, et al.
Nature|December 17, 2008
Enhancing SIV-specific immunity in vivo by PD-1 blockadeVijayakumar Velu, Kehmia Titanji, Baogong Zhu, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 19, 2009
Cold agglutinins in HIV-seropositive participants and diagnosis of respiratory disease due to Mycoplasma pneumoniaeEaski Muthu Shankar, Ramachandran Vignesh, Pachamuthu Balakrishnan, et al.
Cellular Immunology|January 21, 2017
CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptidesMuttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Bioscience (Landmark Edition)|March 27, 2024
Chronic Viral Infection Compromises the Quality of Circulating Mucosal-Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory ReceptorsJaisheela Vimali, Yean K Yong, Amudhan Murugesan, et al.
European Journal of Clinical Investigation|December 19, 2015
Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patientsMuttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, et al.
Innate Immunity|June 14, 2017
Decrease of CD69 levels on TCR Vα7.2<sup>+</sup>CD4<sup>+</sup> innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patientsYean K Yong, Hong Y Tan, Alireza Saeidi, et al.
Frontiers in Immunology|December 15, 2025
No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME studyMarisa R Young, C Christina Mehta, Tyree Staple, et al.
Journal of Viral Hepatitis|April 5, 2024
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradicationShanmugam Saravanan, Esaki M Shankar, Ramachandran Vignesh, et al.
Frontiers in Immunology|August 8, 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus MacaquesTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Pathogens and Disease|November 12, 2013
HIV-Mycobacterium tuberculosis co-infection: a 'danger-couple model' of disease pathogenesisEsaki M Shankar, Ramachandran Vignesh, Rada Ellegård, et al.
Nature|December 17, 2008
Enhancing SIV-specific immunity in vivo by PD-1 blockadeVijayakumar Velu, Kehmia Titanji, Baogong Zhu, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 19, 2009
Cold agglutinins in HIV-seropositive participants and diagnosis of respiratory disease due to Mycoplasma pneumoniaeEaski Muthu Shankar, Ramachandran Vignesh, Pachamuthu Balakrishnan, et al.
Cellular Immunology|January 21, 2017
CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptidesMuttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, et al.
Pageof 11